...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of glaucoma >Outcomes of Ahmed Glaucoma Drainage Implant in Eyes With Glaucoma Secondary to Iridocorneal Endothelial Syndrome
【24h】

Outcomes of Ahmed Glaucoma Drainage Implant in Eyes With Glaucoma Secondary to Iridocorneal Endothelial Syndrome

机译：艾哈迈德青光眼排水植入眼中的结果与伊米多米表综合征中的青光眼植入眼

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Aim: To evaluate the success of Ahmed glaucoma valve (AGV) implantation in patients with glaucoma secondary to iridocorneal endothelial (ICE) syndrome. Materials and Methods: This retrospective study included 18 eyes of 18 patients with ICE syndrome and glaucoma who had undergone AGV implantation at our institute between January 2008 and April 2019. The primary outcome was the success of AGV, defined as intraocular pressure (IOP) >= 6 and <= 21 mm Hg with or without topical antiglaucoma medication (AGM). Failure was defined as IOP 21 mm Hg/need for oral AGM/need for additional glaucoma surgery or loss of light perception because of a surgical complication. Corneal clarity and graft survival in these eyes post-AGV were the secondary outcome measure. Results: The median (interquartile range) follow-up was at 20.61 (3.9 to 57) months. Of the 18 eyes, 14 (77.8%) had adequate IOP control with or without AGMs. Postoperatively, the mean (+/- standard deviation) IOP significantly reduced from 29.7(+/- 10) mm Hg to 16(+/- 3.8) mm Hg and the number of AGMs reduced significantly from a mean of 3.6 (+/- 1) to 1.7 (+/- 0.9). The probability of AGV success was 92.3 +/- 7.4%, 66.1 +/- 11.0%, and 50.5%+/- 17.3% at 1, 3, and 4 years, respectively. All 4 failures were because of uncontrolled IOP and needed either oral AGM or additional surgery for IOP control. At the last follow-up visit, 16 eyes had clear cornea and 2 eyes had pre-existing corneal scar (eccentric) that persisted after AGV implantation. Conclusion: AGV implant was reasonably successful for IOP control in glaucoma secondary to ICE syndrome with a few common but manageable corneal complications.
机译：目的：评估艾哈迈德青光眼瓣膜（AGV）植入患者患有伊米科菌（冰）综合征的青光眼患者的成功。材料和方法：这项回顾性研究包括18名18名患有18名冰综合征患者的眼睛和青光眼，在2008年1月至2019年4月期间在我们的研究所经历了AGV植入。主要结果是AGV的成功，定义为眼压（IOP）> = 6和<= 21 mm Hg，有或没有局部抗触发剂药物（AGM）。失败被定义为IOP 21 mm HG /口服AGM /需要额外的青光眼手术或由于手术并发症而丧失光明感知。这些眼睛的角膜清晰度和移植物存活后AGV是次要结果措施。结果：中位数（四分位数）随访时间为20.61（3.9至57）个月。 18只眼睛，14（77.8％）有足够的IOP对照，有或没有AGMS。术后，平均值（+/-标准偏差）IOP从29.7（+/- 10）mm Hg到16（+/- 3.8）mm Hg，而AGM的数量明显减少3.6（+/- 1）至1.7（+/- 0.9）。 AGV成功的概率分别为92.3 +/- 7.4％，66.1 +/- 11.0％，分别为1,3和4年的50.5％+ / - 17.3％。所有4个故障都是因为不受控制的IOP，并且需要口服AGM或IOP控制的额外手术。在最后一次后续访问中，16只眼睛有透明角膜，2只眼睛有预先存在的角膜疤痕（偏心）仍然存在于AGV植入后持续存在。结论：AGV植入合理成功用于IOP对冰综合征的青光眼控制，具有少数常见但可管理的角膜并发症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号